- Morrison, V.A. (1994) "Chronk leukemias", CA: A Cancer Journal for Clinicans 44, 353-377.
- Andriole, V.T. (1999) "The 1998 Garrod lecture: Current and future antifungal therapy: new target for antifungal agents", Journal of Antimicrobial Chemotherapy 44, 151-162.
- Sheehan, D.J., Hitchcock, C.A. and Sibley, C.M. (1999) "Current and emerging azole antifungal agents", Clinical Microbiology Reviews 12, 40-79.
- Ji, H., Zhang, W., Zhou, Y., Zhang, M., Zhu, J., Song, Y. and Lü, J. (2000) "A three-dimensional model of lanosterol 14 alpha-demethylase of Candida albicans and its interaction with azole antifungals", Journal of Medicinal Chemistry 43, 2493-2505.
- Georgopapadakou, N.H. and Walsh, T.J. (1996) "Antifungal agents: chemotherapeutic targets and immunological strategies", Antimicrobial Agents and Chemotherapy 40, 279-291.
- Di Domenico, B. (1999) "Novel antifungal drugs", Current Opinion in Microbiology 2, 509-515.
- Birch, M.G., Robson, G., Law, D.L. and Denning, D.W. (1996) "Evidence of multiple extracellular phospholipase activities of Aspergillus fumigatus", Infection and Immunity 64, 751-755.
- Ghannoum, M.A. (2000) "Potential role of phospholipases in virulence and fungal pathogenesis", Clinical Microbiology Reviews 13, 122-143.
- Dillard, R.D., Bach, N.J., Draheim, S.E., Berry, D.R., Carlson, D.G., Chirgadze, N.Y., Clawson, D.K., Hartley, L.W., Johnson, L.M., Jones, N.D., McKinney, E.R., Mihelich, E.D., Olkowski, J.L., Schevitz, R.W., Smith, A.C., Snyder, D.W., Sommers, C.D. and Wery, J.P. (1996) "Indole inhibitors of human nonpancreatic secretory phospholipase A2", Journal of Medicinal Chemistry 39, 5119-5136.
- Schevitz, R.W., Bach, N.J., Carlson, D.G., Chirgadze, N.Y., Clawson, D.K., Dillard, R.D., Draheim, S.E., Hartley, L.W., Jones, N.D. and Mihelich, E.D. (1995) "Structure-based design of the first potent and elective inhibitor of human nonpancreatic secretory phospholipase A2", Nature and Structure in Biology 2, 458-465.
- Le Borgne, M., Na, Y.M., Pagniez, F., Le Baut, G., Le Pape, P. and Abdala, H. (2000) "Composition pharmaceutique antifongique et/ou antiparasitaire et nouveaux dérivés de l'indole à titre de principes actifs d'une telle composition". French Patent 62937L.
- Pagniez, F. and Le Pape, P. (2001) "New fluorimetric screening test for possible antifungal drugs", Journal de Mycologie Médicale 11, 73-78.
- Arthington-Skaggs, B.A., Warnock, D.W. and Morrison, C.J. (2000) "Quantitation of Candida albians ergosterol content improves the correlation between in vitro antifungal susceptibility test results and in vivo outcome after fluconazole treatment in a murine model of invasive candidiasis", Antimicrobial Agents and Chemotherapy 44, 2081-2085.
- Le Pape, P., Zidane, M., Abdala, H. and More, M.T. (2000) "A glycoprotein isolated from a sponge, Pachymatisma johnstonii, has anti-leishmanial activity", Cell Biology International 1, 51-56.
- Moreau, P., Milpied, N., Fayette, N., Ramee, J.F. and Harousseau, J.L. (1992) "Reduced renal toxicity and improved clinical tolerance of amphotericin B mixed with intralipid compared with conventional amphotericin B in neutropenic patients", Journal of Antimicrobial Chemotherapy 30, 535-541.
- Musial, CE., Cockerill, III, F.R. and Roberts, G.D. (1988) "Fungal infections of the immunocompromised host clinical and laboratory aspects", Clinical Microbiology Reviews 1, 1992-1996.
- Diamond, R.D. (1991) "The growing problem of mycoses in patients infected with the human immunodeficiency virus", Review of Infectious Diseases 13, 480-486.
- Borgers, M., Van de Ven, M.A. and Van Cutsem, J. (1989) "Structural degeneration of Aspergillus fumigatus after exposure to saperconazole", Journal of Medical and Veterinary Mycology 27, 381-389.
- Yoshida, Y. (1988) "Cytochrome P450 of fungi: primary target for azole antifungal agents", Current Topics in Medical Mycology 2, 388-418.
- Koltin, Y. and Hitchcock, C.A. (1997) "Progress in the research for new triazole antifungal agents", Current Opinion in Chemical Biology 1, 176-182.
Free access
In Vitro Activity of a New Antifungal Azolyl-substituted Indole Against Aspergillus fumigatus
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.